Invention Grant
- Patent Title: Pharmaceutical formulations of tranexamic acid and their use
- Patent Title (中): 氨甲环酸的药物制剂及其用途
-
Application No.: US14325630Application Date: 2014-07-08
-
Publication No.: US09301936B2Publication Date: 2016-04-05
- Inventor: Matthew James Buderer , Jeffrey Joel Abrams
- Applicant: Imprimis Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Imprimis Pharmaceuticals, Inc.
- Current Assignee: Imprimis Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Lathrop & Gage LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A01N37/18 ; A61K31/195 ; A61K31/167 ; A61K31/19 ; A61K31/245 ; A61K31/407 ; A61K31/7048 ; A61K38/12 ; A61K45/06 ; A61K9/06 ; A61K9/00 ; A61K9/02 ; A61K31/18 ; A61K31/351 ; A61K31/65
Abstract:
The present invention relates to pharmaceutical formulations comprising tranexamic acid, kits thereof, and methods for treating bleeding by local administration.
Public/Granted literature
- US20150038406A1 PHARMACEUTICAL FORMULATIONS OF TRANEXAMIC ACID AND THEIR USE Public/Granted day:2015-02-05
Information query
IPC分类:
